Patents by Inventor Mitchell H. Babkes
Mitchell H. Babkes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190008669Abstract: An intragastric implant for obesity treatment is disclosed. The device delays digestion by providing a duodenal sleeve, and may also slows gastric emptying by limiting flow through the pyloric sphincter. The implant includes an elongated axially-compressible duodenal sleeve having a non-tissue-piercing anchor on a proximal end sized to lodge within the duodenal bulb. The anchor may have oppositely-directed anchoring flanges to resists migration in both directions. The sleeve may also have barbed ribs to resist proximal movement back up into the stomach. A method of implant includes collapsing/compressing the device and transorally advancing it through the esophagus to be deployed within the duodenum. A dissolvable jacket may constrain the implant for delivery and naturally dissolve upon implant. Removal of the implant may occur in the reverse.Type: ApplicationFiled: September 10, 2018Publication date: January 10, 2019Applicant: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Zachary P. Dominguez, Christopher S. Mudd
-
Patent number: 10070980Abstract: An intragastric implant for obesity treatment is disclosed. The device delays digestion by providing a duodenal sleeve, and may also slows gastric emptying by limiting flow through the pyloric sphincter. The implant includes an elongated axially-compressible duodenal sleeve having a non-tissue-piercing anchor on a proximal end sized to lodge within the duodenal bulb. The anchor may have oppositely-directed anchoring flanges to resists migration in both directions. The sleeve may also have barbed ribs to resist proximal movement back up into the stomach. A method of implant includes collapsing/compressing the device and transorally advancing it through the esophagus to be deployed within the duodenum. A dissolvable jacket may constrain the implant for delivery and naturally dissolve upon implant. Removal of the implant may occur in the reverse.Type: GrantFiled: June 18, 2013Date of Patent: September 11, 2018Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Mitchell H. Babkes, Zachary P. Dominguez, Christopher S. Mudd
-
Patent number: 9956105Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may provide slowed entry into the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Some devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse. The implants are formed of materials that permit the implant to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach.Type: GrantFiled: October 14, 2015Date of Patent: May 1, 2018Assignee: Apollo Endosurgery US, Inc.Inventors: Mitchell H. Babkes, Zachary P. Dominguez
-
Patent number: 9895247Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Also, certain devices slow gastric emptying by blocking or otherwise impeding flow through the pyloric sphincter. A number of devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: GrantFiled: April 6, 2015Date of Patent: February 20, 2018Assignee: Apollo Endosurgery US, Inc.Inventors: Mitchell H. Babkes, Zachary P. Dominguez, Justin Schwab
-
Patent number: 9895246Abstract: Transoral implantable devices includes an inflatable body made of a material that permits it to be compressed into a substantially linear transoral delivery configuration and that when implanted in the stomach is adapted to reduce obesity or weight by stimulating the stomach walls of the patient. The body has a plurality of popout features on its surface that reside generally flush with the inflatable body in relaxed, refracted states, and which respond to an increase in pressure within the inflatable body by projecting outward from the body in a stressed, deployed state. The popout features may convert between their retracted and deployed states by movement of rolling diaphragms formed in the inflatable body.Type: GrantFiled: February 12, 2015Date of Patent: February 20, 2018Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Justin Schwab, Mitchell H. Babkes
-
Patent number: 9801747Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, or the greater and lesser curvatures in the middle of the stomach, to stimulate satiety-inducing nerves. Some devices may combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: GrantFiled: January 29, 2015Date of Patent: October 31, 2017Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Justin J. Schwab, Mitchell H. Babkes, Jason Metzner, Zachary P. Dominguez
-
Patent number: 9795498Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: GrantFiled: October 3, 2013Date of Patent: October 24, 2017Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Publication number: 20170258617Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, or the greater and lesser curvatures in the middle of the stomach, to stimulate satiety-inducing nerves. Some devices may combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.Type: ApplicationFiled: May 30, 2017Publication date: September 14, 2017Applicant: Apollo Endosurgery US, Inc.Inventors: Justin J. Schwab, Mitchell H. Babkes, Jason Metzner, Zachary P. Dominguez
-
Patent number: 9681974Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: GrantFiled: October 21, 2014Date of Patent: June 20, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Mitchell H. Babkes, Justin Schwab, Christopher S. Mudd, Jason Metzner
-
Patent number: 9668901Abstract: Intragastric fluid transfer devices and related methods for operation thereof are disclosed. The intragastric fluid transfer devices and related methods are intended to assist a patient in maintaining a healthy body weight by stimulating the inner stomach walls and/or the inner duodenum walls. Features of the intragastric fluid transfer device include insertion of the devices transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these intragastric fluid transfer devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer.Type: GrantFiled: July 9, 2013Date of Patent: June 6, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Joseph Raven, Mitchell H. Babkes
-
Publication number: 20170143523Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive implants do not autonomously change shape, but instead react within the stomach to induce satiety. The implants may take up volume within the stomach, thus reducing the digestive capacity. Additionally, the implants may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Also, a number of implants slow gastric emptying by blocking or otherwise impeding flow through the pyloric sphincter. Other implants delay digestion by providing a duodenal sleeve. A number of implants combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the implants within a delivery tube and transorally advancing the implants through the esophagus to be deployed within the stomach. Removal of the implants occurs in the reverse.Type: ApplicationFiled: January 10, 2017Publication date: May 25, 2017Applicant: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Zachary Dominguez
-
Publication number: 20170105861Abstract: A mechanism for removing a fluid-filled object such as an intragastric balloon from a patient. The apparatus includes a delivery tube having a lumen and a retrieval tool able to slide within the lumen that can both puncture and grasp the intragastric balloon. The retrieval tool may have sharpened graspers with either a sharp tip and/or knife-like edges. Alternatively, the delivery tube itself may have sharpened cutting blades that deploy outward to puncture the intragastric balloon. One embodiment utilizes a suction cup tip on the delivery sheath and a sharpened puncture rod that extends past the distal tip of the lumen, for rapid deflation of a balloon. Various embodiments hasten the deflation process and simplify the manipulation required by the surgeon.Type: ApplicationFiled: December 29, 2016Publication date: April 20, 2017Applicant: Apollo Endosurgery, Inc.Inventors: Justin J. Schwab, Tiago Bertolote, Zachary P. Dominguez, Mitchell H. Babkes, Richard Law
-
Patent number: 9610184Abstract: A mechanism for removing a fluid-filled object such as an intragastric balloon from a patient. The apparatus includes a delivery tube having a lumen and a retrieval tool able to slide within the lumen that can both puncture and grasp the intragastric balloon. The retrieval tool may have sharpened graspers with either a sharp tip and/or knife-like edges. Alternatively, the delivery tube itself may have sharpened cutting blades that deploy outward to puncture the intragastric balloon. One embodiment utilizes a suction cup tip on the delivery sheath and a sharpened puncture rod that extends past the distal tip of the lumen, for rapid deflation of a balloon. Various embodiments hasten the deflation process and simplify the manipulation required by the surgeon.Type: GrantFiled: April 20, 2015Date of Patent: April 4, 2017Assignee: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Tiago Bertolote, Zachary P. Dominguez, Mitchell H. Babkes, Richard Law
-
Publication number: 20170065444Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: ApplicationFiled: October 10, 2016Publication date: March 9, 2017Applicant: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Sean Snow
-
Patent number: 9539133Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive implants do not autonomously change shape, but instead react within the stomach to induce satiety. The implants may take up volume within the stomach, thus reducing the digestive capacity. Additionally, the implants may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Also, a number of implants slow gastric emptying by blocking or otherwise impeding flow through the pyloric sphincter. Other implants delay digestion by providing a duodenal sleeve. A number of implants combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the implants within a delivery tube and transorally advancing the implants through the esophagus to be deployed within the stomach. Removal of the implants occurs in the reverse.Type: GrantFiled: June 28, 2013Date of Patent: January 10, 2017Assignee: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Zachary Dominguez
-
Patent number: 9498365Abstract: An intragastric obesity treatment implant promotes a feeling of satiety in the patient by contacting the insides of the stomach wall, reducing the space in the stomach, or otherwise reducing the amount of food consumed. One intragastric obesity treatment implant two inflatable balloons coupled via a flow restrictor through which fluid may flow in response to peristaltic motions of a patient's stomach. Additionally, one implant comprises a pumping chamber coupled to a reservoir, where the pumping chamber moves stomach fluids into the reservoir in response to peristaltic motions of the patient's stomach.Type: GrantFiled: October 17, 2011Date of Patent: November 22, 2016Assignee: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Zachary Dominguez, Christopher S. Mudd, Craig Olroyd, Jonathan Daugusta
-
Publication number: 20160331568Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: ApplicationFiled: October 3, 2013Publication date: November 17, 2016Applicant: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Patent number: 9468720Abstract: In one embodiment, the handheld injection device includes a first housing having a first axis and a second housing having a second axis. In one embodiment, the second housing is configured to support a needle. In one embodiment, the first axis and a second axis form an adjustable angle between about 180 degrees and about 90 degrees.Type: GrantFiled: November 12, 2013Date of Patent: October 18, 2016Assignee: Allergan, Inc.Inventors: Christopher S. Mudd, Mitchell H. Babkes, Zachary Dominguez, Michael J. Prichard, Martha E. Llewellyn, Shaohui Qiu, Lee F. Powers, Brett R. Johnson
-
Patent number: 9463107Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: GrantFiled: October 12, 2011Date of Patent: October 11, 2016Assignee: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Sean Snow
-
Patent number: 9398969Abstract: A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices may not autonomously change shape, but instead react within the stomach to induce satiety. The devices may provide slowed entry into the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, to stimulate satiety-inducing nerves. Some devices combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse. The implants are formed of materials that permit the implant to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach.Type: GrantFiled: May 14, 2012Date of Patent: July 26, 2016Assignee: Apollo Endosurgery, Inc.Inventor: Mitchell H. Babkes